ICD-10 Code for Cologuard Screening
The appropriate ICD-10 code for Cologuard (multitarget stool DNA) screening in average-risk, asymptomatic patients is Z12.11 (Encounter for screening for malignant neoplasm of colon).
Primary Screening Code
For routine colorectal cancer screening with Cologuard in asymptomatic patients aged 45 years or older at average risk, use:
- Z12.11 - This is the standard screening code for colorectal cancer screening procedures, including stool-based tests like Cologuard (multitarget stool DNA-FIT test)
The USPSTF recommends colorectal cancer screening starting at age 45 years for average-risk adults, and Cologuard (referred to as sDNA-FIT in guidelines) is an approved screening modality 1.
Code for Abnormal Results
If the Cologuard test returns positive/abnormal, the appropriate code changes:
- R19.5 - Abnormal fecal test (other abnormal findings on examination of stool)
This code should be documented within 30-90 days of an abnormal result, as timely coding with R19.5 is associated with significantly higher colonoscopy completion rates (40.9% vs 16.8% when coded appropriately) 2.
Clinical Context
Average-risk screening criteria (when Z12.11 applies):
- Age 45 years or older
- No prior colorectal cancer, adenomatous polyps, or inflammatory bowel disease
- No personal or family history of Lynch syndrome or familial adenomatous polyposis
- Asymptomatic patients 1
Screening interval: Cologuard should be performed every 1-3 years per USPSTF modeling, though every 3 years is the typical recommended interval 1.
Common Pitfalls
- Do not use Z12.11 if the patient has symptoms (rectal bleeding, abdominal pain, change in bowel habits) - use symptom-specific codes instead
- Do not use Z12.11 for high-risk patients with personal/family history of colorectal cancer or genetic syndromes - use appropriate personal/family history codes (Z80.0, Z86.010)
- Always add R19.5 when results are positive to facilitate appropriate follow-up colonoscopy tracking 2
- Failure to code R19.5 within 30 days of abnormal results is associated with poor colonoscopy completion rates